This page contains a Flash digital edition of a book.
Jigar Choksey


jigar.choksey.wg12@wharton.upenn.edu Northwestern University, Evanston, IL B.S., Magna Cum Laude, Biomedical Engineering and Economics, 2007


R. Carter Clement


rutledge.clement.wg12@wharton.upenn.edu Princeton University, Princeton, NJ B.S.E., Structural Engineering & Architecture, 2004 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M.D. Candidate, 2012


Daniel Cuevas Rimoch


daniel.cuevas.rimoch.wg12@wharton.upenn.edu Universidad Iberoamericana, Mexico City Bachelor in Industrial Engineering, 2008


An opportunity to analyze, invest in and improve healthcare companies.


Bank of America Merrill Lynch, San Francisco, CA Summer Associate, Investment Banking, Summer 2011 Focused on healthcare coverage on the West coast, primarily including biopharmaceutical and medical devices companies. Advised financial sponsors and strategic companies on the poten- tial buyout and acquisition, ~$600M, of a medical devices. Provided a bio- pharma with asset acquisition recom- mendations based on a comprehensive overview of interested marketed and pipeline clinical assets in prostate cancer.


Booz & Company, Chicago, IL Senior Consultant, 2009-2010 Consultant, 2007-2009 Collaborated with clients to complete cases in strategic planning, portfolio management, due diligences and capability building. Engagements primarily focused in healthcare across the entire value chain: payor, provider, biopharma and other services such as PBM and Health IT. Advised acquisition targets for life, disability and dental insurance company. Conducted due diligence for acquisition targets to expand client’s business from $200M to $500M in annual premiums. Pro- vided a U.S. and international growth strategy for hospital software vendor. Wrote a pharmaceutical and biotech- nology R&D industry effectiveness study; study published in “In Vivo” magazine.


An opportunity to combine my clinical and business experiences to develop and implement novel approaches for the delivery of healthcare.


Children’s Hospital of Philadelphia, Philadelphia, PA Operations Consultant, 2010-2011 Participated in a series of three internal-improvement initiatives while in medical and business school. Work was aimed at improving operational efficiency and financial impact of cur- rent systems for patient discharge, sur- gical case planning, and operating room setup. Involvement included leadership positions and extensive project management experience.


Penn Biotech Group, Philadelphia, PA Intern/Consultant, 2008-2010 Served as project manager for a team of 7 University of Pennsylvania gradu- ate students on a consulting project for a major medical device company that involved identifying physician preferences and redesigning clinical supplies. Awarded prize for outstand- ing project of the semester. Worked on a second team for a major health in- surance firm to develop a business case for a new product.


BroadReach Healthcare, Cape Town, ZA Operations Consultant, 2006-2007 Awarded Princeton-in-Africa fellow- ship to spend a year with this health- care consulting firm’s non-profit branch in South Africa. Worked on a capacity building engagement aimed at expanding HIV treatment at 9 South African public hospitals. Over the course of the year, moved into a proj- ect manager role to streamline processes and improve operational efficiency.


An opportunity in healthcare real estate where I can leverage my experience in real estate banking with my expertise in the pharmaceutical industry.


A.T. Kearney, Mexico City Summer Associate, 2011 Assessed Chief Purchasing Officer on optimal sourcing strategy for 30 key inputs purchased by bottling company, with analysis projecting over $60M in annual savings. Investigated differ- ences in purchasing practices across 9 countries for transnational client, rec- ommending sole purchasing process which would avoid over $8M in expenditure control.


Evercore Partners, Mexico City Senior Analyst, 2009-2010 Created financial models using net asset value, discounted cash flow and comparable public companies which were key to propose merger opportu- nities to developers in residential, retail, office, industrial and hotel segments. Developed master plan for $120M tourism-residential project in Baja California. Prepared presenta- tion to target new institutional in- vestors and determined optimal urbanization and edification rate that matched industry’s market demand.


Laboratorios Liomont, Mexico City Project Manager, 2007-2008 Selected by senior management to lead troubled overhaul project. Re-organized project’s Gantt chart to reduce production line stoppage from three to two months and developed contingency plan to produce +1,000,000 units of out-of-stock product during stoppage. Additionally, coordinated Quality Control and Oper- ations Departments in implementation of FDA required technology.


8


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40